13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q1 2024 · Filed April 15, 2024 · Accession 0000950123-24-003318
Total Value
$449.2M
Positions
5
Other Managers
1
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $225.6M | 50.22% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $79.3M | 17.65% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $67.9M | 15.11% |
| 4 | MERUS N V | N5749R100 | 1,169,028 | $52.6M | 11.72% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $23.9M | 5.31% |